Advertisement

Topics

NA | Naproxen Delayed Release [Northwind Pharmaceuticals] | BioPortfolio

12:40 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

NDC: 51655-628-52

MFG: 31722-339-01

Naproxen Delayed Release 500mg

30 tablets

Rx only

Lot#:

Exp. Date:

Each tablet contains naproxen 500 mg

Dosage: See package insert

Store at 68 to 77 degrees F.

Store in a tight, light-resistant container (See USP). Keep out of the reach of children.

Mfg by: InvaGen Pharmaceuticals, Inc Hauppage, NY 11788 for Camber Pharmaceuticals, Piscataway, NJ 08854

Lot#          Exp:

Repackaged by: Northwind Pharmaceuticals, Indianapolis, IN 46256

Manufacturer

Northwind Pharmaceuticals

Active Ingredients

Source

Drugs and Medications [443 Associated Drugs and Medications listed on BioPortfolio]

Naproxen [blenheim pharmacal,inc.]

Naproxen Tablets, USP

Naproxen [physicians total care, inc.]

NA

Naproxen [blenheim pharmacal, inc.]

Naproxen Delayed-release Tablets USP, 375 mg and 500 mg

Naproxen [apotheca inc.]

Naproxen Tablets, USP

Naproxen [proficient rx lp]

Naproxen Tablets, USP

Clinical Trials [2678 Associated Clinical Trials listed on BioPortfolio]

Relative Bioavailability Study of Naproxen Delayed-Release Tablets (375 mg)

The purpose of this study is to demonstrate the relative bioavailability of Naproxen delayed-release tablets (375 mg).

Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg

The objective of this study was to investigate the bioequivalence of Mylan's rabeprazole sodium delayed-release 20 mg tablets to Eisai's Aciphex® delayed-release 20 mg tablets following a...

Trial of YH12852 in Healthy Subjects and Patients With Functional Constipation

A randomized, double-blind/open-label, placebo/active-controlled, single/multiple dose, parallel, phase 1/2a trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynami...

Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis

The purpose of this study is to compare the blood drug levels of two prescribed medications, immediate-release omeprazole 40 mg powder and delayed-release omeprazole 40 mg capsule to deter...

Fast & Fed Pharmacokinetic (PK) Study

The purpose of this study is to provide information on how well an extended release formulation (a medication that is released and absorbed over a longer period of time than a regular rele...

PubMed Articles [5213 Associated PubMed Articles listed on BioPortfolio]

A new pathway for naproxen utilisation by Bacillus thuringiensis B1(2015b) and its decomposition in the presence of organic and inorganic contaminants.

Bacillus thuringiensis B1 (2015b) is a bacterial strain that is able to degrade naproxen. However, the potential effect of water co-contaminations on the degradation process and its pathway have not y...

Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.

Posaconazole delayed-release tablets offer better bioavailability than the liquid suspension, but no post-marketing data are available in immunocompetent hosts such as those with chronic pulmonary asp...

Naproxen ecotoxicity and biodegradation by Bacillus thuringiensis B1(2015b) strain.

High level of naproxen consumption leads to the appearance of this drug in the environment but its possible effects on non-target organisms together with its biodegradation are not well studied. The a...

Effects of Conductive Polyazulene and Plasticizer Embedded in Deproteinized Natural Rubber Transdermal Patch on Electrically Controlled Naproxen Release-Permeation.

Naproxen (Npx) was utilized as an anionic drug and loaded in the deproteinized natural rubber (DPNR) films prepared by the UV irradiation. The in-vitro drug release-permeation from the DPNR films and ...

Syntheses and cytotoxicity of phosphatidylcholines containing ibuprofen or naproxen moieties.

In this study, novel phosphatidylcholines containing ibuprofen or naproxen moieties were synthesized in good yields and high purities. Under the given synthesis conditions, the attached drug moieties ...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record